Centene (CNC) Scheduled to Post Quarterly Earnings on Tuesday

Centene (NYSE:CNC) will announce its earnings results before the market opens on Tuesday, July 23rd. Analysts expect the company to announce earnings of $1.25 per share for the quarter. Centene has set its FY 2019 guidance at $4.24-4.44 EPS and its FY19 guidance at $4.24-4.44 EPS.

Centene (NYSE:CNC) last released its earnings results on Tuesday, April 23rd. The company reported $1.39 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.32 by $0.07. Centene had a return on equity of 14.60% and a net margin of 1.66%. The firm had revenue of $18.44 billion during the quarter, compared to analysts’ expectations of $17.44 billion. During the same quarter last year, the business posted $2.17 earnings per share. The firm’s revenue was up 39.8% on a year-over-year basis. On average, analysts expect Centene to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

Shares of Centene stock opened at $52.66 on Monday. The company’s 50 day moving average price is $53.72. Centene has a 12 month low of $45.44 and a 12 month high of $74.49. The company has a market capitalization of $21.77 billion, a price-to-earnings ratio of 14.88, a PEG ratio of 0.89 and a beta of 0.85. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.04 and a current ratio of 1.04.

CNC has been the subject of a number of research reports. Zacks Investment Research raised Hudson Technologies from a “sell” rating to a “hold” rating in a research note on Wednesday, May 29th. ValuEngine lowered Zumiez from a “hold” rating to a “sell” rating in a research note on Tuesday, July 2nd. Argus increased their price target on Lululemon Athletica to $195.00 and gave the company a “buy” rating in a research note on Friday, March 29th. Credit Suisse Group set a GBX 6,350 ($82.97) price target on AstraZeneca and gave the company a “buy” rating in a research note on Friday, March 29th. Finally, Citigroup reissued a “buy” rating on shares of Healthequity in a research note on Friday, May 10th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $75.77.

About Centene

Centene Corporation operates as a diversified and multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. The company's Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which covers dually eligible individuals, as well as aged, blind, or disabled programs.

Further Reading: Fiduciary

Earnings History for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.